Showing results (251-260 of 365) with videos related to
Sort By:
Pageof 37
Cancer Treatment Reviews|January 20, 2022
Therapeutic implications of germline vulnerabilities in DNA repair for precision oncologyShreya M Shah, Elena V Demidova, Randy W Lesh, et al.The Journal of Thoracic and Cardiovascular Surgery|June 9, 2005
High-dose radiotherapy in trimodality treatment of Pancoast tumors results in high pathologic complete response rates and excellent long-term survivalKing F Kwong, Martin J Edelman, Mohan Suntharalingam, et al.Oncogene|February 23, 2011
Breast tumor progression induced by loss of BTG2 expression is inhibited by targeted therapy with the ErbB/HER inhibitor lapatinibF Takahashi, N Chiba, K Tajima, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2004
Phase II trial of cisplatin/etoposide and concurrent radiotherapy followed by paclitaxel/carboplatin consolidation for limited small-cell lung cancer: Southwest Oncology Group 9713Martin J Edelman, Kari Chansky, Laurie E Gaspar, et al.Lung Cancer (Amsterdam, Netherlands)|April 5, 2016
Epidermal growth factor receptor (EGFR) mutations in small cell lung cancers: Two cases and a review of the literatureBradford J Siegele, Konstantin Shilo, Bo H Chao, et al.Journal of Palliative Medicine|November 27, 2024
End-of-Life Care in Hematology/Oncology FellowshipMadeline J Albert, Yang Liu, Asya Varshavsky, et al.The Journal of Thoracic and Cardiovascular Surgery|August 17, 2020
Resection following concurrent chemotherapy and high-dose radiation for stage IIIA non-small cell lung cancerJessica S Donington, Rebecca Paulus, Martin J Edelman, et al.Cancer Investigation|March 20, 2003
Phase I trial of gemcitabine and paclitaxel in advanced solid tumorsNelson Lim, Primo N Lara, Derick H M Lau, et al.Science Advances|June 12, 2020
Reconstructing the time since death using noninvasive thermometry and numerical analysisLeah S Wilk, Richelle J M Hoveling, Gerda J Edelman, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2009
Preclinical studies of vorinostat (suberoylanilide hydroxamic acid) combined with cytosine arabinoside and etoposide for treatment of acute leukemiasKen Shiozawa, Takeo Nakanishi, Ming Tan, et al.Pageof 37